Glenview Trust Co Invests $438,000 in Agilent Technologies, Inc. $A

Glenview Trust Co bought a new position in Agilent Technologies, Inc. (NYSE:A) in the second quarter, Holdings Channel.com reports. The firm bought 3,296 shares of the medical research company’s stock, valued at approximately $438,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Empowered Funds LLC acquired a new stake in shares of Agilent Technologies during the 2nd quarter valued at about $6,004,000. United Capital Financial Advisors LLC purchased a new stake in shares of Agilent Technologies in the second quarter valued at approximately $817,000. Pacific Heights Asset Management LLC acquired a new position in shares of Agilent Technologies during the 2nd quarter worth approximately $19,924,000. Jefferies Financial Group Inc. purchased a new position in shares of Agilent Technologies during the 2nd quarter valued at approximately $8,392,000. Finally, Public Employees Retirement System of Ohio acquired a new stake in Agilent Technologies in the 2nd quarter valued at $12,433,000.

Agilent Technologies Trading Down 2.0%

Shares of A opened at $154.47 on Friday. The firm has a 50-day moving average price of $140.30 and a 200 day moving average price of $127.04. The firm has a market capitalization of $43.63 billion, a P/E ratio of 30.41, a P/E/G ratio of 2.65 and a beta of 1.25. The company has a current ratio of 2.05, a quick ratio of 1.62 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $163.75.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. The firm had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The firm’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Citigroup lifted their price target on Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Thursday. Bank of America raised their price objective on Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a report on Thursday. HSBC dropped their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Finally, Robert W. Baird upped their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $170.33.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.